The reference multimedia journal in interventional cardiology

issue

Mar 20, 2023

Volume 18 Number 15

A debate on the future of transcatheter mitral valve replacement; a new ESC/EAPCI clinical consensus statement on renal denervation; a minifocus on interventional pharmacology; ticagrelor and prasugrel vs clopidogrel in patients who have undergone PCI for chronic coronary syndromes; the effects of evolocumab on platelet reactivity from the POMPEII registry: pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing PCI; a periprocedural bolus of cangrelor for comatose survivors of out-of-hospital cardiac arrest undergoing PCI and target temperature management; impact of non-fatal periprocedural major adverse events on ten-year mortality; pathologic responses to abluminal biodegradable versus circumferential durable polymer-coated DES; and more…

In this issue of EuroIntervention

An ESC/EAPCI consensus statement on renal denervation; a debate on the future of transcatheter mitral valve replacement; a mini focus on interventional pharmacology, from P2Y12 inhibitors to evolocumab; impact of non-fatal periprocedural major adverse events on ten-year mortality; pathologic responses to abluminal biodegradable versus circumferential durable polymer-coated DES; and more

Capodanno D

free

Editorial

Revascularisation, periprocedural events and survival – and the survival of the randomised controlled trial

Lansky AJ, Ahmad Y

10.4244/EIJ-E-23-00004

free

Debate

Transcatheter mitral valve replacement will remain a niche therapy: pros and cons

Cohen D, Ludwig S, Piazza N

10.4244/EIJ-E-22-00044

free

Interventions for hypertension and stroke

Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Barbato E, Azizi M, Schmieder R, Lauder L, Böhm M, Brouwers S, Bruno RM, Dudek D, Kahan T, Kandzari D, Lüscher T, Parati G, Pathak A, Ribichini F, Schlaich M, Sharp AS, Sudano I, Volpe M, Tsioufis C, Wijns W, Mahfoud F

10.4244/EIJ-D-22-00723

free

Coronary interventions - Mini focus on interventional pharmacology

Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes

Koshy A, Giustino G, Sartori S, Hooda A, Feng Y, Snyder C, Dasgupta S, Kumar K, Krishnamoorthy-Melarcode P, Sweeny J, Khera S, Serrao G, Sharma R, Dangas G, Kini A, Mehran R, Sharma S

10.4244/EIJ-D-22-00654

free

Editorial comment

Clopidogrel: still king of the ring for elective percutaneous coronary intervention!

Montalescot G, Ferrante A

10.4244/EIJ-E-23-00003

free

Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study

Franchi F, Ortega-Paz L, Rollini F, Been L, Rivas A, Maaliki N, Zhou X, Pineda A, Suryadevara S, Soffer D, Zenni M, Angiolillo D

10.4244/EIJ-D-22-00719

free

Editorial comment

Effects of PCSK9 inhibitors on platelet function

Räber L, Ueki Y

10.4244/EIJ-E-23-00005

free

Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry

Gargiulo G, Marenna A, Sperandeo L, Manzi L, Avvedimento M, Simonetti F, Canonico M, Paolillo R, Spinelli A, Borgia F, Diserafino L, Franzone A, Stabile E, Piccolo R, Cirillo P, Valgimigli M, Esposito G

10.4244/EIJ-D-22-00594

free

Cangrelor for comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention: the CANGRELOR-OHCA study

Kordis P, Bozic Mijovski M, Berden J, Steblovnik K, Blinc A, Noc M

10.4244/EIJ-D-22-00675

free

Coronary interventions

Impact of periprocedural major adverse events on 10-year mortality after revascularisation

Kotoku N, Serruys PW, Ninomiya K, Soo A, Masuda S, Kageyama S, Revaiah PC, Mack MJ, Holmes DR, Morice M, Davierwala P, Mohr F, Milojevic M, Kappetein A, Garg S, Onuma Y

10.4244/EIJ-D-22-00681

free

Editorial comment

Periprocedural adverse events after revascularisation: the importance of getting off to a good start

Gaudino M, Dimagli A

10.4244/EIJ-E-22-00054

free

Early vascular responses to abluminal biodegradable polymer-coated versus circumferential durable polymer-coated newer-generation drug-eluting stents in humans: a pathological study

Kawagoe Y, Otsuka F, Onozuka D, Ishibashi-Ueda H, Ikeda Y, Ohta-Ogo K, Matsumoto M, Amemiya K, Asaumi Y, Kataoka Y, Nishimura K, Miyamoto Y, Noguchi T, Finn AV, Virmani R, Hatakeyama K, Yasuda S

10.4244/EIJ-D-22-00650

free

Letter to the editor

Letter: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?

Minten L, Bennett J, Dubois C

10.4244/EIJ-D-22-00998

free

Reply: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?

Sabbah M, Lønborg J, Olsen NT, Engstrøm T

10.4244/EIJ-D-22-01031

free